Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Christy S. Harris"'
Autor:
Christy S. Harris, Kristine B. Marcus, Eliza Dy-Boarman, Emily Chan, Eric G. Boyce, Nancy S. Yunker, Angela L. Bingham, Susan E. Smith, Stuart T. Haines, Maya R. Chilbert, Mojdeh S. Heavner, Scott A. Chapman, Kyle Strnad
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 3:692-695
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::352dbb6bdab5059b3f331da8ac181856
https://doi.org/10.1002/jac5.1241
https://doi.org/10.1002/jac5.1241
Autor:
Jay L. Martello, Winter J. Smith, Lisa M. Avery, Elizabeth Rogers, Janet P. Engle, Megan C. Herink, Christy S. Harris, Sara Jane E. Faro, Katherine G. Moore, Emily J. Ashjian, Paul M. Stranges, Barkha Jain, Eric J. MacLaughlin, Jill S. Borchert, John M. Burke
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 3:124-132
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d782d0830bbadf232142fe39fdeb57c
https://doi.org/10.1002/jac5.1200
https://doi.org/10.1002/jac5.1200
Autor:
Bonnie A Labdi, Rebecca J Fahrenbruch, Janelle Perkins, Lisa M. Holle, Alexandre Chan, Cory M. Vela, Jocelyn E Mohs, Christy S Harris, LeAnn B. Norris
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 23(3)
Background Oncology pharmacists are capable of providing medication therapy management (MTM) because of their level of training, practice experiences, and responsibilities. Very little data exist about their current practice, including changing roles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e038c9fed59d1bd5d441d00187684eb
https://pubmed.ncbi.nlm.nih.gov/26854267
https://pubmed.ncbi.nlm.nih.gov/26854267
Autor:
Frank Cirrone, Anne M. McDonnell, Donna Neuberg, David C. Fisher, Yang Feng, Audrea Szabatura, Daniel Voit, Christy S Harris, James E. Butrynski
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 21(3)
Purpose Ifosfamide-induced encephalopathy is a neurotoxic adverse effect of ifosfamide chemotherapy. The objective of this study was to determine the incidence of encephalopathy in patients with lymphoma and sarcoma receiving ifosfamide chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66827dedf78d78bad72e3ae9eed30af7
https://pubmed.ncbi.nlm.nih.gov/24664476
https://pubmed.ncbi.nlm.nih.gov/24664476
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 20(1)
Docetaxel-associated palmar-plantar erythrodysesthesia is rarely reported in literature, particularly when used in the treatment of sarcomas. Here, we report a case of docetaxel-related palmar-plantar erythrodysesthesia in a 28-year-old male with rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::756a4aeaa6a83284a6f21a690f1af87e
https://pubmed.ncbi.nlm.nih.gov/23478198
https://pubmed.ncbi.nlm.nih.gov/23478198
Autor:
Frank Cirrone, Christy S Harris
Publikováno v:
Clinical therapeutics. 34(10)
Background Vismodegib is an oral inhibitor of the Hedgehog pathway approved by the US Food and Drug Administration. It is the first systemic treatment for patients with locally advanced or metastatic basal cell carcinoma that is not amenable to surge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0376d62d8ff6da165d92669963f6db04
https://pubmed.ncbi.nlm.nih.gov/23036338
https://pubmed.ncbi.nlm.nih.gov/23036338
Autor:
Frances Fuller, Kimmie Ng, Sharon Lane, Audrea Szabatura, Carole Kathleen Dalby, Robin Sommers, Susanne Conley, Phuong Nguyen, Patricia Rizzo, Janet Bagley, Christy S Harris
Publikováno v:
Journal of Clinical Oncology. 32:146-146
146 Background: In 2013 ASCO and ONS published guidelines to promote safe practices for oral chemotherapy use. These agents can have significant toxicities and pose safety risks without proper adherence. Guided by the ASCO/ONS recommendations, Dana-F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20ef4eacd542a13816d95d54a3bd6349
https://doi.org/10.1200/jco.2014.32.30_suppl.146
https://doi.org/10.1200/jco.2014.32.30_suppl.146